TrialDoor helps patients and their physicians evaluate potential clinical trials the way an oncologist would, examining each trial in detail with a focus on effectively matching each patient to the most appropriate trial. Every U.S. pancreatic cancer trial in the NIH clinicaltrials.gov database is scored daily across 13 clinical dimensions using TrialDoor’s proprietary, diagnosis-specific rubric refined over thousands of human-reviewed iterations. Dedicated processes for additional cancer diagnoses are planned for release in the coming months.

After a brief secure patient input form is completed, the application instantly scores each trial for that specific patient, filters out poor fits and displays the best fits first, reducing the number of trials patients, families, and physicians need to review. An interactive dashboard offers the user further customization of the results, and the final trial set can be easily exported as a pdf report, or as a csv file for importing into a spreadsheet.

The platform is fully secure, encrypted end-to-end, and collects no personal patient identifiers or contact information. AI assists in developing the clinical logic but never touches patient data. TrialDoor is free to use and independent from any healthcare network or pharmaceutical company - it is born from a family caregiver’s determination to help others find better options.